91 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
, state of facts, effect or occurrence results from (1) fraud by POINT or any POINT Subsidiary or (2) the FDA issuing one or more orders that impose … , circumstance, state of facts, effect or occurrence, to the extent resulting from such fraud or order, may be taken into account in determining whether
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
, SSN, or other identifying information, without your permission, to commit fraud or other crimes. An identity thief may use your SSN to get a job or may
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
, condition, development, circumstance, state of facts, effect or occurrence results from (1) fraud by the Company or any Company Subsidiary or (2 … such change, event, condition, development, circumstance, state of facts, effect or occurrence, to the extent resulting from such fraud or order, may
8-K
EX-2.1
s4jsr3qabz4j3jzo
3 Oct 23
Tender and Support Agreement
7:35am
ARS
ficmgs6wh36
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
essefp8
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
c4l5ry6i u8ogzfg
1 Jul 22
Shelf registration
4:13pm
424B3
EX-31.2
3252ykxv
13 May 22
Prospectus supplement
8:18am